Isis Makes Quick Gain From Ortho-McNeil Pact, Enters Phase I For Novel Diabetes Candidate

Firm also will present positive Phase II data on novel small molecule targeting apolipoprotein B-100 for treatment of familial hypercholesterolemia later this week.